Last reviewed · How we verify
NCT03405675: SLAS
Gerontology Research Programme: The Singapore Longitudinal Ageing Studies (SLAS I & II)
trial testing SLAS 1 in Cognitive Changes Due to Organic Disorder (Finding) in 6,183 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | National University of Singapore |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 6,183 |
| Start date | 1 July 2003 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- SLAS 1
- SLAS 2
Conditions studied
- Cognitive Changes Due to Organic Disorder (Finding) — all drugs for Cognitive Changes Due to Organic Disorder (Finding) →
- Dementia — all drugs for Dementia →
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
- Frailty — all drugs for Frailty →
Sponsor
National University of Singapore
Who can join
55 and older, any sex, with Cognitive Changes Due to Organic Disorder (Finding) or Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Gerontology Research Programme (GRP) in the National University Singapore's Department of Psychological Medicine, was formed to coordinate and facilitate the conduct of multi-disciplinary research on in a wide range of research on ageing and health. The establishment of the Singapore Longitudinal Aging Cohort will provide a large community-based cohort of elderly subjects for observational studies with useful clinical applications. Research synergy is achieved in terms of pooling multi-disciplinary expertise, and combining genetic, biological, environmental, behavioural, social, clinical, and health services approaches to gerontological research.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Singapore multidisciplinary consensus recommendations on muscle health in older adults: assessment and multimodal targeted intervention across the continuum of care.
Chew STH, Kayambu G, Lew CCH, Ng TP, et al · · 2021 · cited 19× · PMID 34001023 · DOI 10.1186/s12877-021-02240-8 -
Functional mobility decline and incident mild cognitive impairment and early dementia in community-dwelling older adults: the Singapore Longitudinal Ageing Study.
Ng TP, Lee TS, Lim WS, Chong MS, et al · · 2022 · cited 17× · PMID 36074716 · DOI 10.1093/ageing/afac182 -
Friendly visiting by a volunteer for reducing loneliness or social isolation in older adults: A systematic review.
Laermans J, Scheers H, Vandekerckhove P, De Buck E. · · 2023 · cited 10× · PMID 38034902 · DOI 10.1002/cl2.1359 -
Curcumin-rich curry consumption and life expectancy: Singapore longitudinal ageing study.
Ng TP, Nyunt SZ, Gao Q, Gwee X, et al · · 2024 · cited 7× · PMID 37306893 · DOI 10.1007/s11357-023-00842-1 -
Dairy and fish consumption and the risk of mild cognitive impairment and dementia
Chua DQL, Gwee X, Gao Q, Nyunt MSZ, et al · · 2020 · cited 1× · DOI 10.21203/rs.3.rs-36469/v1 -
Differential metabolomic prediction of outcomes in HFpEF and HFrEF: a prospective international multi-ethnic cohort study.
Wu LH, Pakkiri LS, Tromp J, Lim PL, et al · · 2026 · PMID 42035244 · DOI 10.1093/cvr/cvag090
Verify or expand the search:
- PubMed search for NCT03405675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other National University of Singapore trials
Trials by the same sponsor.
- NCT07519642 — Frailty Improvement Through Technology With Informal Caregiver Supported Exercise (FITWISE) for Pre-frail and Frail Comm · NA · not yet recruiting
- NCT07525492 — Die-logue Program for Community Dwelling Adults: A Randomized Controlled Trial · NA · not yet recruiting
- NCT07375459 — Community-based Mobile-assisted Brief Intervention for Smoking Cessation · NA · recruiting
- NCT07444073 — Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock · not yet recruiting
- NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03405675 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National University of Singapore
- Last refreshed: 14 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03405675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing